FundedIQ
Biotechnology

YGION Biomedical: Funding, Investors & Team (Sep 2026)

Austria's YGION Biomedical is dedicated to turning personalized cancer immunotherapy into a viable option.

www.ygion.bio LinkedIn Austria, Philippines 1-10 employees
Biotechnology Oncology Therapeutics B2C
Total raised
$16.3M
Rounds
1
Latest
Series A
May 2024

YGION Biomedical has raised $16.3M across 1 funding round on record, the most recent a Series A of $16.3M announced in May 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

YGION Biomedical Company Profile and Key Stats

Total funding raised
$16.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$16.3M in May 2024
Employees
1-10
reported band
Headquarters
Austria, Philippines

Latest funding round on record: May 2024.

YGION Biomedical Funding Rounds

Date
Round
Amount
Series A
$16.3M

YGION Biomedical Founders and Leadership Team

Name
Role
Contact
Gottfried Himmler
Founder

No contact details are on record for this team yet.

YGION Biomedical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
97
$4.9M
8,422
$15M

YGION Biomedical's latest round of $16.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like YGION Biomedical in Biotechnology and Austria

Companies Similar to YGION Biomedical

Preventix, created by the Mexican research laboratory Timser, is a novel screening test that uses a minimally…

Seed $3.5M

Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…

Undisclosed round $4.2M

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…

Seed $17.4M

Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…

Seed $410k

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

YGION Biomedical Funding FAQs

What does YGION Biomedical do?

Austria's YGION Biomedical is dedicated to turning personalized cancer immunotherapy into a viable option.

How much funding has YGION Biomedical raised?

YGION Biomedical has raised $16.3M across 1 round on record. The most recent is a Series A of $16.3M announced in May 2024.

When did YGION Biomedical last raise funding?

YGION Biomedical's most recent funding round on record is a Series A of $16.3M, announced in May 2024.

Who founded YGION Biomedical?

FundedIQ lists Gottfried Himmler (Founder) at YGION Biomedical.

Where is YGION Biomedical headquartered?

YGION Biomedical is based in Austria, Pangasinan, Philippines.

How many employees does YGION Biomedical have?

YGION Biomedical is in the 1-10 employee band.

How does YGION Biomedical's funding compare to other Biotechnology startups?

YGION Biomedical's latest round of $16.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's YGION Biomedical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for YGION Biomedical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.